Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Integrity Applications Incorporation (OTC: IGAP).

Full DD Report for IGAP

You must become a subscriber to view this report.


Recent News from (OTC: IGAP)

Integrity Applications Receives First Order from CuraTec Nordic for GlucoTrack®
Wilmington, DE and Ashdod, Israel, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack® , a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has received its firs...
Source: GlobeNewswire
Date: August, 14 2018 09:15
Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries
Wilmington, DE and Ashdod, Israel, July 25, 2018 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP) (“Integrity” or “Integrity Applications”) announced today that it has entered into an exclusive distribution agreement with ...
Source: GlobeNewswire
Date: July, 25 2018 09:15
Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Non-Invasive Glucose Monitoring Device in the Netherlands
WILMINGTON, Del. and ASHDOD, Israel , Dec. 28, 2017 /PRNewswire/ --  Integrity Applications, Inc . ("Integrity") (OTCQB: IGAP), innovator of GlucoTrack® , a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today th...
Source: PR Newswire
Date: December, 28 2017 09:30
Integrity Applications Announces Re-Order of GlucoTrack® Devices
WILMINGTON, Del. and ASHDOD, Israel , Nov. 1, 2017 /PRNewswire/ --  Integrity Applications, Inc. (OTCQB: IGAP) ("Integrity" or the "Company"), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announc...
Source: PR Newswire
Date: November, 01 2017 16:15
Integrity Applications Announces Strategic Corporate Update
Near-term Priorities Include GlucoTrack Commercialization in Europe and GlucoTrack US FDA Approval Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack ® , a non-invasive device for measuring glucose levels in people with Type 2 diabetes, announced a strategic co...
Source: Business Wire
Date: October, 23 2017 09:15
Daily OTC Markets Round-Up - 9/19/2017
This article is part of an ongoing series which provides information relevant to stocks on the OTC markets on a daily basis. It provides stocks with the most daily volume, and the biggest winners/losers in terms of changes in stock price. It then provides information on the stocks which have e...
Source: SeekingAlpha
Date: September, 20 2017 13:23
A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes
WILMINGTON, Del. and ASHDOD, Israel , Sept. 7, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, presents Data Demonstrating that the performance of GlucoTrac...
Source: PR Newswire
Date: September, 07 2017 09:40
GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal
WILMINGTON, Del. and ASHDOD, Israel , Sept. 5, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, announced today that it will be attending the 53rd Annua...
Source: PR Newswire
Date: September, 05 2017 09:15

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-130.150.150.150.1513,800
2018-12-120.130.140.140.131,600
2018-12-110.120.120.120.121,000
2018-12-100.200.140.200.142,500
2018-12-070.200.200.200.202,500

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-101,5002,50060.0000Short
2018-11-29514,5050.0345Cover
2018-11-075,00010,19049.0677Short
2018-10-265,0007,50066.6667Short
2018-10-171,7604,00044.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IGAP.


About Integrity Applications Incorporation (OTC: IGAP)

Logo for Integrity Applications Incorporation (OTC: IGAP)

Integrity Applications is a medical device company focused on the design, development and commercialization of non invasive glucose monitoring devices for diabetes patients. The GlucoTrack R model DF F is CE Mark Approved since June . The company focuses now in preparation for mass production and distribution agreements.

 

Contact Information

 

 

Current Management

  • John Graham / CEO
  • Sami Sassoun / CFO
  • David Malka / VP, Ops.
  • David Podwalski / Chief Commercial Officer
  • John Graham / Chairman
  • Robert Fischell /
  • Revan Schwartz /
  • Leslie Seff /
  • Angela Strand /

Current Share Structure

  • Market Cap: $11,739,587 - 03/16/2018
  • Authorized: 40,000,000 - 09/30/2016
  • Issue and Outstanding: 6,521,993 - 11/14/2017

 


Recent Filings from (OTC: IGAP)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 07 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 06 2018
Information for Proxy Statement under Rule 14a-101
Filing Type: DEFR14AFiling Source: edgar
Filing Date: March, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 28 2017
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: December, 26 2017
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: December, 21 2017

 

 


Daily Technical Chart for (OTC: IGAP)

Daily Technical Chart for (OTC: IGAP)


Stay tuned for daily updates and more on (OTC: IGAP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: IGAP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IGAP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IGAP and does not buy, sell, or trade any shares of IGAP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/